首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

2126652

疫苗輸送裝置市場：依產品類型、給藥途徑、最終用戶和地區分類。

Vaccine Delivery Devices Market, By Product Type, By Route of Administration, By End User, By Geography

出版日期: 2026年08月13日 | 出版商:

Coherent Market Insights | 英文 254 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，疫苗輸送設備市場規模將達到 85 億美元，到 2033 年將達到 142 億美元。預計 2026 年至 2033 年的複合年成長率將達到 7.6%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	85億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	7.60%	2033年市場規模預測：	142億美元

該市場正經歷持續成長，主要促進因素包括全球疫苗接種率和免疫接種率的提高、各國免疫規劃的擴展、感染疾病發病率的上升以及對更安全、更有效率的疫苗輸送技術日益成長的需求。疫苗輸送裝置是用於透過各種途徑輸送疫苗的系統，包括注射器、噴射注射器、微針、氣溶膠/乾粉吸入系統、鼻腔給藥裝置和皮內給藥裝置。

醫療衛生系統和免疫機構正日益重視安全、便捷且擴充性的疫苗接種技術，以提高免疫接種率並減少對傳統方法的依賴。儘管注射器因其在常規和大規模免疫接種項目中的廣泛應用而仍然是最大的產品類型，但諸如無針噴射注射器、微針貼片、皮內給藥系統和預充式預填充等新興技術正在創造新的成長機會。先進疫苗接種系統的日益普及也有助於改善偏遠和資源匱乏地區民眾獲得疫苗接種的機會。

市場動態

由於國家免疫規劃的持續擴展、新疫苗的推出、免疫接種率的提高以及大規模免疫和補種計劃的實施，市場呈現出強勁的成長勢頭。注射劑和醫療設備免疫接種的每一次擴展都持續帶動了對注射器、針頭、皮內注射裝置、噴射注射器和其他疫苗輸送系統的需求。各國政府、聯合國兒童基金會、全球疫苗免疫聯盟、醫院和其他醫療機構實施的大規模機構採購計劃，也持續為疫苗輸送裝置提供了強勁且穩定的需求基礎。

人們日益關注更安全、更有效率的疫苗接種方式，這進一步推動了市場成長。自動失效注射器、可重複使用注射器、安全設計裝置、預充式注射器和無針給藥系統正被擴大採用，以提高注射安全性、簡化預填充式注射器並支持大規模疫苗接種計劃。世界衛生組織的預認證要求和聯合國兒童基金會的大規模採購框架也鼓勵製造商加強品質標準並擴大其安全注射裝置的生產能力。

替代給藥技術的日益普及也在再形成市場格局。噴射注射器和皮內給藥系統正從臨床評估階段過渡到大規模免疫接種計畫的部署階段，而微陣列疫苗貼片因其無針給藥、熱穩定性更高、分發更便捷等優勢，正處於臨床開發階段。同時，市場對預填充即用型疫苗製劑的需求不斷成長，推動了對高擴充性生產技術的投資。

北美預計仍將是最大的區域市場，這得益於其成熟的免疫基礎設施、完善的醫院和藥房免疫網路、較高的常規疫苗和季節性疫苗接種率，以及對先進疫苗接種技術的早期應用。亞太地區預計將實現最快成長，這主要得益於大規模人群免疫計劃、不斷擴大的醫療基礎設施、疫苗獲取途徑的改善以及國內疫苗和注射器生產能力的提升。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數分析疫苗輸送設備市場主要公司的概況：公司概況、產品系列、主要亮點、財務績效和策略。
本報告提供的見解將使行銷負責人和企業經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
《疫苗給藥設備市場》報告的目標受眾是該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析疫苗輸送設備市場中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Panacea Pharmaceuticals
- 3M
- Biojet Medical Technologies Pharmajet
- Valeritas
- Vaxxas
- Gerresheimer
- Schott AG
- Corium International
- Becton Dickinson & Company
分析師意見

第9章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI903

Vaccine Delivery Devices Market is estimated to be valued at USD 8.5 Bn in 2026 and is expected to reach USD 14.2 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 8.5 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.60%	2033 Value Projection:	USD 14.2 Bn

The market is witnessing sustained growth mainly driven by increasing global vaccination and immunization coverage, expansion of national immunization programs, rising incidence of communicable diseases, and growing demand for safer and more efficient vaccine administration technologies. Vaccine delivery devices are systems used to administer vaccines through different routes and include syringes, jet injectors, microneedles, aerosol/dry powder inhalation systems, intranasal delivery devices, and intradermal delivery devices.

Healthcare systems and immunization agencies are increasingly focusing on safe, easy-to-use, and scalable delivery technologies to improve vaccination coverage and reduce dependence on conventional administration methods. Syringes continue to represent the largest product category owing to their established use across routine and mass immunization programs, while emerging technologies such as needle-free jet injectors, microneedle patches, intradermal systems, and ready-to-administer prefilled formats are creating new growth opportunities. The increasing adoption of advanced vaccine delivery systems is also supporting vaccination access in remote and resource-constrained settings.

Market Dynamics

The market is witnessing major momentum owing to the continued expansion of national vaccination schedules, introduction of newer vaccines, increasing immunization coverage, and implementation of large-scale vaccination and catch-up programs. Every expansion in injectable or device-administered vaccination generates recurring demand for syringes, needles, intradermal devices, jet injectors, and other vaccine administration systems. Large institutional procurement programs undertaken by governments, UNICEF, Gavi, hospitals, and other healthcare organizations continue to provide a strong recurring demand base for vaccine delivery devices.

The growing emphasis on safer and more efficient vaccine administration is further fueling market growth. Auto-disable syringes, reuse-prevention syringes, safety-engineered devices, prefilled syringes, and needle-free delivery systems are increasingly being adopted to improve injection safety, simplify administration, and support high-volume vaccination programs. WHO prequalification requirements and large-scale UNICEF procurement frameworks are also strengthening quality standards and encouraging manufacturers to expand production capabilities for safe injection equipment.

The increasing adoption of alternative delivery technologies is also reshaping the market. Needle-free jet injectors and intradermal systems are progressing from clinical evaluation toward large-scale immunization programs, while microarray vaccine patches are advancing through clinical development owing to their potential for needle-free administration, improved thermostability, and simplified distribution. At the same time, growing preference for prefilled and ready-to-administer vaccine delivery formats is encouraging investments in scalable manufacturing technologies.

North America is expected to remain the largest regional market, supported by mature vaccination infrastructure, established hospital and pharmacy vaccination networks, high utilization of routine and seasonal vaccines, and early adoption of advanced vaccine delivery technologies. Asia Pacific is expected to witness the fastest growth owing to large population-based immunization programs, expanding healthcare infrastructure, increasing vaccine accessibility, and strengthening domestic vaccine and syringe manufacturing capabilities.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Vaccine Delivery Devices Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Panacea Pharmaceuticals, 3M, Biojet Medical Technologies Pharmajet, Valeritas, Vaxxas, Gerresheimer, Schott AG, Corium International, and Becton Dickinson & Company.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Vaccine Delivery Devices Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Vaccine Delivery Devices Market

Market Segmentation

By Product Type (Revenue, USD Bn, 2021-2033)
Syringes
Jet Injectors
Micro needles
Aerosol/dry powder inhalation
Intranasal delivery devices
Intradermal delivery devices
By Route of Administration (Revenue, USD Bn, 2021-2033)
Intradermal
Intramuscular
Subcutaneous
Others
By End User (Revenue, USD Bn, 2021-2033)
Hospitals
Clinics
Others
By Region (Revenue, USD Bn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players
Panacea Pharmaceuticals
3M
Biojet Medical Technologies Pharmajet
Valeritas
Vaxxas
Gerresheimer
Schott AG
Corium International
Becton Dickinson & Company

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Vaccine Delivery Devices Market, By Product Type, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Jet Injectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Micro needles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Aerosol/dry powder inhalation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Intranasal delivery devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Intradermal delivery devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Global Vaccine Delivery Devices Market, By Route of Administration, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Intradermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Global Vaccine Delivery Devices Market, By End User, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

7. Global Vaccine Delivery Devices Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Panacea Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- 3M
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Biojet Medical Technologies Pharmajet
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Valeritas
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Vaxxas
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Gerresheimer
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Schott AG
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Corium International
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Becton Dickinson & Company
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views